| NAME |
POSACONAZOLE 300MG/PKT PWDR,RENST-ORAL,EC |
| VA GENERIC NAME |
POSACONAZOLE |
| DOSAGE FORM |
PWDR,RENST-ORAL |
| HAZARDOUS TO DISPOSE |
NO |
| FORMULARY DESIGNATOR TEXT |
Restricted to ID/Hematology/Oncology or other facility authorized providers
|
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
300 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| UNITS |
MG/PKT |
| NATIONAL FORMULARY NAME |
POSACONAZOLE PWDR,RENST-ORAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2023-05-17 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
POSACONAZOLE 300MG/PKT RENST-ORAL PWDR |
| VA PRODUCT IDENTIFIER |
P1325 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
PKT |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4042242 |
| EFFECTIVE DATE/TIME |
-
- 2023-05-18 00:00:00
- STATUS: ACTIVE
|
